Clinical Trial Update: Evaluation of In-lab Benefit for Speech-in-noise Intelligibility With Device for Adults With Mild to Moderate Hearing Loss [NA]

View source ↗

Summary

A clinical trial evaluating a hearing device to improve speech-in-noise intelligibility in adults with mild-to-moderate hearing loss has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hearing Loss

Snippet

Sponsor: Luxottica Group S.p.A. | Conditions: Hearing Loss | NA | Status: COMPLETED